Online assessment, about 3 minutes

Start your assessment

Clear answers make a better plan, and a clinician takes it from there.

Step 1 of 6 Goals

What are your goals?

Pick every goal that applies. Your clinician helps you narrow it down.

Peptide therapy is clinician-guided, where appropriate. The evidence is still emerging.

About you

Used to calculate your BMI and confirm eligibility with your clinician.

Age

Height

Feet

Inches

Weight (lb)

Your BMI Updates as you type.

Health history

Select anything that applies to you. Choose None of these if nothing does.

Personal or family history of medullary thyroid cancer or MEN 2 Pregnant or planning pregnancy History of pancreatitis Gallbladder disease Type 1 diabetes Kidney disease None of these

Current medications

Include prescriptions, over-the-counter products, supplements and doses.

Medications and supplements

None: I take no medications or supplements

Where do you live?

Availability depends on the states where your clinician is licensed.

State of residence

Review your answers

Check each section. Edit anything that is wrong.

Important Safety Information

WARNING: RISK OF THYROID C-CELL TUMORS. Semaglutide and tirzepatide cause thyroid C-cell tumors in rodents. It is unknown whether they cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in people. These medicines are not for people with a personal or family history of MTC or of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain and reduced appetite. Serious side effects include pancreatitis, gallbladder problems, low blood sugar (especially with other diabetes medicines), and kidney problems, which can follow dehydration from vomiting or diarrhea.

These medicines are not for use in pregnancy. A licensed clinician decides whether a medicine is appropriate for you. Individual results vary.